Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
VVV heads into its November earnings with short sellers adding exposure, analysts trimming targets, and a stock that has already punished investors badly once this year.
The short position tells the most urgent story. Short interest has climbed to nearly 11% of the free float, up 8% over the past month and adding another 1% this week alone. That is a meaningfully large and growing bet against the stock. The ORTEX short score sits at 62, roughly in the middle of the range, but has been drifting between 61 and 64 for the past two weeks without a clear directional break. Borrow conditions remain relaxed. Availability is running at around 300%, meaning roughly three shares are available to lend for every one already borrowed. The cost to borrow is just 0.51%, up about 9% on the week but still extremely cheap. New shorts face no friction entering the trade. Against this, options positioning has actually turned more bullish than normal. The put/call ratio is 0.49, below its 20-day average of 0.63 and 0.7 standard deviations below the mean, suggesting the derivatives market is not hedging for a sharp selloff even as short interest rebuilds. The two signals are pointing in different directions.
The Street is more cautious than it was three months ago. Barclays lowered its target to $39 from $41 this week, maintaining Equal-Weight. Citi cut to $34 from $41 last week, keeping a Neutral. Both firms are trimming without changing their stance, a pattern that usually reflects downward estimate revisions rather than a fundamental change of view. The bull camp, led by RBC with an Outperform and a $49 target, and TD Cowen with a Buy at $45, points to same-store sales momentum near 8 to 9% and a long store-growth runway at a network of roughly 2,200 locations. The bear case is more immediate: FY26 guidance implies a roughly 340 to 380 basis point year-on-year margin compression in the current quarter, and finished lubricant costs that could end the period around 60% higher than a year ago. The mean analyst target is $43, implying about 40% upside from the current $30.73 close, though the gap between the bulls and the newly cautious Citi target at $34 illustrates how wide the dispersion has become. Valuation has compressed with the stock: the PE multiple is 12.9 times, down about 3 points over the past month, and EV/EBITDA is 8.1 times, also contracting. EPS momentum remains the standout factor score at 96th percentile over 30 days and 90th over 90 days, suggesting the earnings revision cycle has been strongly positive even as the stock has weakened.
The earnings reaction history adds a sobering frame. The most recent print, in August, sent VVV down 9.3% on the day and a further 15.2% over the following five days. That magnitude of post-earnings selloff is not background noise. It reflects a market that is willing to punish a miss severely at this stock. The next event is scheduled for November 20.
Insider activity over the past 90 days has been modestly net negative in value terms, around $75,000 sold against minimal open-market buying. The most notable datapoint is CFO Kevin Willis, who made a $318,000 open-market purchase in May at $31.80 per share. The stock is trading within a dollar of that price today. That purchase was not under a 10b5-1 plan. The Chief Accounting Officer added roughly $50,000 in August at $33.20. Neither trade is large by institutional standards, but both were discretionary buys from people inside the company, and both were made at prices close to today's level. Among major holders, BlackRock added around 370,000 shares as of September 30. Neuberger Berman built a position by over 840,000 shares. Cooke and Bieler trimmed by roughly 646,000 shares. No 13D activist is on the register.
Wikipedia attention for VVV is running about 1.9 standard deviations above its own 90-day average, a measure of retail attention rather than a revenue signal. There are no alt-data datasets with a measured lead on VVV's financials.
With 43 days to the November 20 earnings date, the key question is whether lubricant cost inflation proves manageable or forces the margin miss the bears are pricing in. Short interest is growing into a stock already down 4% over the past month. Availability is loose. The August reaction suggests the market will not give VVV the benefit of the doubt.
See the live data behind this article on ORTEX.
Open VVV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
